DrugBank is a curated pharmaceutical knowledge base. Follow our page for interesting updates and stories about the world of pharmacology.
Employees: 11-50
Mentions in press and media 5
| Date | Title | Description |
| 06.04.2020 | IBM Research releases a new set of cloud- and artificial intelligence-based COVID-19 resources | https://d1rytvr7gmk1sx.cloudfront.net/wp-content/uploads/2020/03/20200324_Scott_Karen_3D_TR.mp4 More must-read AI coverage NVIDIA moves to front of the AI pack AI investments soared in 2021, but big problems remain Forrester: AI may be used... |
| 18.07.2019 | A bird’s-eye view of clinical trials provides new perspectives on drug research and development | Waste and inefficiency in drug development are big problems. They can be hard to spot, especially when you are in the midst of the process. A new way of visualizing clinical trials might help. Some experts believe that as much as 85% of bio... |
| 24.06.2019 | Edmonton’s Entrepreneurial Spirit Shines Through | While Edmonton might be known for many things including being home to North America's largest mall and a cultural and governmental center in the Alberta province, the city is building a reputation for its innovative and entrepreneurial spi... |
| 19.12.2012 | UVA spinoff using calcium channel blockers to improve cancer treatment gets $3M for trials | Tau is taking a bold move by hinging its lead product on mibefradil, which was formerly marketed by Roche for the treatment of hypertension. It was voluntarily withdrawn from the market in 1998 because of potentially harmful interactions wi... |
| - | UVA spinoff using calcium channel blockers to improve cancer treatment gets $3M for trials | A company repositioning drugs used to treat high blood pressure for use in improving chemotherapy has secured $3 million from investors to carry its lead candidate through Phase 1 trials. Tau Therapeutics is repurposing the calcium channel ... |